Arkolith/Insider Trading/ENZ/Form 4

Cannon Kara

Chief Executive Officer, DirectorENZO BIOCHEM INC (ENZ) · full profile →Form 4 · filed Feb 27, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 23, 2024Grant(A)150K—$0451K
Feb 21, 2024Option exercise(M)11K—$0307K
Feb 21, 2024Tax withholding(F)6K—$0301K

Transaction Codes

A
Grant / award
M
Option exercise / conversion
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-24-017640) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML